Sign inJoin waitlistJoin the waitlist

AP

Aimee Pierce

Clinical Core Lead · Oregon Health & Science University

Credentials: · · · ·

History

Layton Aging and Alzheimer’s Disease Center · Oregon Health & Science University
Present
Oregon Health & Science University
Present

UCLA David Geffen School of Medicine/UCLA Medical Center
Neurology
University of California-Los Angeles
2004–2008
Columbia Univ Coll of Phys & Surgeons
2000–2004

Research

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Nature Genetics · 2017 · 798 citations
Model-guided microarray implicates the retromer complex in Alzheimer's disease
Annals of Neurology · 2005 · 353 citations

Jeffrey Kaye
7 papers
Jeffrey Burns
6 papers
Liana Apostolova
6 papers
Andrew Saykin
5 papers
Eric Reiman
5 papers
Henry Paulson
5 papers
Lawrence Honig
5 papers · 1 as a resident
RW
Randy Woltjer
5 papers
TB
Thomas Beach
5 papers
AB
Adam Boxer
4 papers
Allan Levey
4 papers
Amanda Smith
4 papers

Grants

Oregon Alzheimer's Disease Research Center
National Institute on Aging · P30
Project lead · $6.2M · Oregon Health & Science University
2020–2030
The Alzheimer's Disease Research Center at the University of California, Irvine
National Institute on Aging · P50
Project lead · $472.6K · University of California-Irvine

Clinical trials

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2028
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Site PI · Recruiting
University of Southern California
2021–2027